Thus, the first major contribution of the current population study is to demonstrate that the detection of circulating apoE4 above a level of 30,000 pg/mL, assessed from DBS in a population‐based survey, shows associations with cognition, independent of other known risk factors of cognitive decline. The gene discussed is APOE; the disease is Mental deterioration.